(Q33990192)

30 July 2017

0 references

1 reference

title

Homocysteine, methylenetetrahydrofolate reductase and risk of schizophrenia: a meta-analysis (English)

1 reference

30 July 2017

0 references

1 reference

Blom HJ

3

1 reference

ORCID Public Data File 2021

author name string

Muntjewerff JW

series ordinal

1

1 reference

30 July 2017

Kahn RS

series ordinal

2

1 reference

30 July 2017

den Heijer M

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

30 July 2017

number of pages

7

1 reference

inferred from page(s)

published in

Molecular Psychiatry

1 reference

30 July 2017

volume

11

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

143-149

1 reference

A critical review of genetic studies of schizophrenia. II. Molecular genetic studies

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Schizophrenic illness in the families of schizophrenic adoptees: findings from the Danish national sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Biochemistry of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Effects of amino acid feedings in schizophrenic patients treated with iproniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Tracer kinetic evidence for abnormal methyl metabolism in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Disturbances of one-carbon metabolism in neuropsychiatric disorders: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Hyperhomocysteinemia, methylenetetrahydrofolate reductase 677TT genotype, and the risk for schizophrenia: a Dutch population based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

On estimating the relation between blood group and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Elevated homocysteine levels in young male patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Homocysteine metabolism and B-vitamins in schizophrenic patients: low plasma folate as a possible independent risk factor for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Homocysteine levels in newly admitted schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Folate, homocysteine, and negative symptoms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Methylenetetrahydrofolate reductase gene polymorphisms in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

No association between polymorphisms of methylenetetrahydrofolate reductase gene and schizophrenia in both Chinese and Scottish populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Genetic analysis of the thermolabile methylenetetrahydrofolate reductase variant in schizophrenia and mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Meta-analysis of genetic association studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Facts and recommendations about total homocysteine determinations: an expert opinion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Homocysteine, folate, methylation, and monoamine metabolism in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Enhancement of recovery from psychiatric illness by methylfolate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

The neurodevelopmental hypothesis of schizophrenia: a review of recent developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

Schizophrenia epigenesis: past, present, and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

7 January 2021

Schizophrenia: a new approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

7 January 2021

Demethylation of C14 2,3,4-trimethoxyphenylethylamine in schizophrenics before and after L-methionine loading

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

7 January 2021

Folate-responsive homocystinuria and "schizophrenia". A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

7 January 2021

Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

7 January 2021

Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

7 January 2021

Homocysteinemia is a common feature of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

7 January 2021

Schizophrenia and impaired homocysteine metabolism: a possible association

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

7 January 2021

Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

7 January 2021

Methylenetetrahydrofolate reductase variant and schizophrenia/depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

7 January 2021

C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

7 January 2021

Association between the methylenetetrahydrofolate reductase 677C-->T missense mutation and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

7 January 2021

Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

7 January 2021

Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001746

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001746

1 reference

Dimensions Publication ID

30 July 2017

1006642890

0 references

1 reference